Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer.

Konner J, Schilder RJ, DeRosa FA, Gerst SR, Tew WP, Sabbatini PJ, Hensley ML, Spriggs DR, Aghajanian CA.

Gynecol Oncol. 2008 Aug;110(2):140-5. doi: 10.1016/j.ygyno.2008.04.018. Epub 2008 Jun 13.

PMID:
18554700
2.

Dose-dense approaches to ovarian cancer treatment.

Katsumata N.

Curr Treat Options Oncol. 2015 May;16(5):21. doi: 10.1007/s11864-015-0338-4. Review.

PMID:
25859831
3.
4.

Bevacizumab combination therapy: for the first-line treatment of advanced epithelial ovarian, fallopian tube or primary peritoneal cancer.

Dhillon S.

Drugs. 2012 May 7;72(7):917-30. doi: 10.2165/11208940-000000000-00000. Review.

PMID:
22515620

Supplemental Content

Support Center